1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-W020017S3
    Propanoic acid-d5

    丙酸-d5

    Inhibitor 99.94%
    Propanoic acid-d5 是氘代标记的 Propanoic acid (HY-W020017)。Propanoic acid 是一种口服活性短链脂肪酸。Propanoic acid 可由肠道细菌 (bacteria) 代谢膳食纤维而产生。Propanoic acid 增加 PPAR-γ,抑制 NF-κB 活化、降低 COX-2 表达和 NO 生成。Propanoic acid 诱导凋亡 (Apoptosis) 和自噬 (Autophagy)。Propanoic acid 减轻 HSV-1 诱发的眼角膜炎。Propanoic acid 对胶质母细胞瘤具有抗癌作用。Propanoic acid 具有神经保护、抗氧化和抗炎活性。Propanoic acid 可用于脊髓损伤、阿尔茨海默症研究。
    Propanoic acid-d<sub>5</sub>
  • HY-34411
    Phloroglucinol Inhibitor
    Phloroglucinol 是一种有效的 NIK 抑制剂,具有抗氧化和抗炎活性。Phloroglucinol 抑制核因子-κB (NF-κB)、细胞外信号调节激酶 (ERK) 和 c-Jun N-末端激酶 (JNK) 等信号通路,清除活性氧 (ROS) ,降低炎症介质 (如 TNF-α、IL-1β、IL-6、PGE2) 和基质金属蛋白酶 (MMPs) 的表达。Phloroglucinol 有望用于关节炎、动脉粥样硬化等慢性炎症相关疾病的研究。
    Phloroglucinol
  • HY-153516
    NIK-IN-2 Inhibitor 99.00%
    NIK-IN-2 (compound 1) 是 NF-κB 诱导激酶 (NIK) 的有效抑制剂,其 pIC50 为 7.4。NIK-IN-2 在癌症研究中发挥着重要作用。
    NIK-IN-2
  • HY-101410R
    SDMA (Standard)

    对称二甲基精氨酸 (Standard)

    Activator
    SDMA (Standard)是 SDMA 的分析标准品。本产品用于研究及分析应用。SDMA (Symmetric dimethylarginine)是一氧化氮 (NO) 合酶活性的内源性抑制剂。SDMA 是一种新的肾脏生物标志物,可以比传统的肌酐检测更早地诊断肾脏疾病。
    SDMA (Standard)
  • HY-B1619S
    Cromolyn-d5

    色甘酸-d5

    Inhibitor
    Cromolyn-d5 (Cromoglycate-d5) 是 Cromolyn (HY-B1619) 的氘代物。 Cromolyn (Cromoglycate) 是一种口服有效的 GSK-3β 抑制剂,IC50 为 2.0 μM。Cromolyn 也是一种肥大细胞稳定剂,能抑制肥大细胞释放介质、调节反射性支气管收缩和降低非特异性支气管高反应性,可用支气管哮喘的研究。此外,Cromolyn 还具有抗炎、抗过敏、抗组胺、抗肿瘤和神经保护等多种活性。
    Cromolyn-d<sub>5</sub>
  • HY-W012349
    2′-Hydroxychalcone

    2'-羟基查尔酮

    Inhibitor
    2'-Hydroxychalcone 是查尔酮的羟基衍生物,具有抗癌活性。2'-Hydroxychalcone 抑制 NF-κB 通路并诱导乳腺癌细胞自噬 (autophagy) 和凋亡 (apoptosis)。2′-Hydroxychalcone 对复合副球孢子菌属显示出更好的抗真菌活性。
    2′-Hydroxychalcone
  • HY-B0190B
    Nafamostat hydrochloride

    盐酸萘莫司他

    Nafamostat hydrochloride,一种抗凝剂,是一种人工合成的丝氨酸蛋白酶 (serine protease) 抑制剂。Nafamostat hydrochloride 具有抗癌和抗病毒作用,Nafamostat hydrochloride 通过上调肿瘤坏死因子受体 1 (TNFR1) 的表达诱导凋亡 (apoptosis),可用于动脉壁病理性增厚的发生发展。
    Nafamostat hydrochloride
  • HY-19498
    WAY-204688 Inhibitor 99.89%
    WAY-204688 是雌激素受体 (ER-α) 选择性的,口服活性的 NF-κB 转录活性抑制剂。在 HAECT 细胞中,作用于NF-κB-Luc 荧光素酶,IC50 为 122 ± 30 nM。
    WAY-204688
  • HY-152169
    BIHC Inhibitor ≥98.0%
    BIHC 是一种 TNF 阻断剂,具有抗炎活性。BIHC 可显著抑制肝细胞癌 (HCC) 细胞增殖,并对 HepG2 细胞系具有强效的细胞毒性,可以诱导细胞凋亡 (apoptosis ),且对正常肝细胞的毒性较小。BIHC 可以用于炎症性肠病 (IBD) 的研究。
    BIHC
  • HY-B0898R
    Ceftiofur sodium (Standard)

    头孢噻呋钠 (Standard)

    Inhibitor
    Ceftiofur sodium (Standard) 是 Ceftiofur sodium (HY-B0898) 的分析标准品。本产品用于研究及分析应用。Ceftiofur sodium 是一种靶向细菌青霉素结合蛋白 (PBPs) 的细胞壁合成抑制剂,在内毒素血症中具有抗炎作用。Ceftiofur sodium 通过抑制细菌细胞壁肽聚糖的合成发挥杀菌作用,导致细菌细胞裂解。Ceftiofur sodium 还抑制 NF-κBMAPKs 的激活,从而减少 TNF-α、IL-1β 和 IL-6 等促炎细胞因子的分泌。
    Ceftiofur sodium (Standard)
  • HY-117726
    WAY-169916 Inhibitor 99.60%
    WAY-169916 是一种雌激素受体的途径选择性配体,通过抑制 NF-kB 转录活性发挥作用。WAY-169916 具有抗炎活性。
    WAY-169916
  • HY-135317B
    Emavusertib hydrochloride Inhibitor
    Emavusertib hydrochloride (CA-4948 tosylate) 是 Emavusertib (HY-135317) 的盐酸盐形式。Emavusertib hydrochloride 是口服有效的 IRAK4 (IC50=57 nM) 和 FLT3 抑制剂。Emavusertib hydrochloride 可抑制 NF-κBMyD88 信号通路,减少促炎细胞因子(如 IL-6 和 IL-10)的产生,从而表现出抗炎和对癌细胞的抗增殖活性,诱导细胞凋亡 (apoptosis)。Emavusertib hydrochloride 在小鼠模型中表现出抗肿瘤活性。
    Emavusertib hydrochloride
  • HY-N2908R
    Atraric acid (Standard) Inhibitor
    Atraric acid (Standard)是 Atraric acid 的分析标准品。本产品用于研究及分析应用。Atraric acid (Methyl atrarate) 是一种特异的雄激素受体 (androgen receptor) 拮抗剂,具有抗炎和抗癌作用。Atraric acid 抑制 LNCaP 和 C4-2 细胞中内源性前列腺特异性抗原基因的表达。Atraric acid 还能抑制 NO 和细胞因子的合成,抑制 MAPK-NFκB 信号通路。At
    Atraric acid (Standard)
  • HY-B2082R
    Fursultiamine (Standard)

    呋喃硫胺 (Standard)

    Inhibitor
    Fursultiamine (Standard)是 Fursultiamine 的分析标准品。本产品用于研究及分析应用。Fursultiamine 是一种维生素 B1 衍生物,具有抗伤害和抗肿瘤活性。Fursultiamine 可用于维生素 B1 缺乏病,骨关节炎 (OA) 和癌症研究。Fursultiamine 还能够减轻缺氧条件诱导的 VEGF 分泌和线粒体分裂。
    Fursultiamine (Standard)
  • HY-N0629R
    Maslinic acid (Standard)

    山楂酸 (Standard)

    Inhibitor
    Maslinic acid (Standard) 是 Maslinic acid 的分析标准品。本产品用于研究及分析应用。Maslinic acid 可抑制 NF-κB p65 的 DNA 结合活性, 并消除 IκB-α 磷酸化。
    Maslinic acid (Standard)
  • HY-B0612R
    Lercanidipine (Standard)

    乐卡地平 (Standard)

    Inhibitor
    Lercanidipine (Standard) 是 Lercanidipine 的分析标准品。本产品用于研究及分析应用。Lercanidipine 是第三代、亲脂性、可穿透血脑屏障、血管选择性、具有口服活性的二氢吡啶钙通道阻断剂,pIC50 为 7.74(由 微摩尔浓度 转换而来)。Lercanidipine 具有持久的降压作用以及肾脏和神经保护作用,还具有抗氧化、抗炎和抗凋亡的特性。Lercanidipine 可用于心血管和神经学研究[1]<
    Lercanidipine (Standard)
  • HY-N0738R
    Stachydrine hydrochloride (Standard)

    盐酸水苏碱 (Standard)

    Inhibitor
    Stachydrine hydrochloride (Standard) 是 Stachydrine hydrochloride 的分析标准品。本产品用于研究及分析应用。Stachydrine hydrochloride 是益母草的主要活性成分,可用于心血管疾病的研究。Stachydrine hydrochloride 可以抑制 NF-κB 信号通路。具有抗心肌肥大活性 。
    Stachydrine hydrochloride (Standard)
  • HY-13559
    Atiprimod Inhibitor
    Atiprimod (Azaspirane) 是一种 STAT3 抑制剂,具有抗肿瘤、抗炎和抗血管生成活性。Atiprimod 通过抑制信号转导和转录激活因子 STAT3 的磷酸化,阻断 IL-6VEGF 的信号通路。Atiprimod 通过抑制 JAK2JAK3 的磷酸化来阻断 JAK-STAT 信号通路。Atiprimod 抑制细胞增殖,诱导细胞周期阻滞,并引发自噬 (autophagy) 和凋亡 (apoptosis)。Atiprimod 通过激活 PERK/eIF2α/ATF4/CHOP 轴并抑制 STAT3/NF-κB 转录因子的核转位,触发乳腺癌细胞中持续的内质网应激介导的凋亡 (apoptosis)。Atiprimod 在肿瘤异种移植小鼠模型中显示出显著的抗肿瘤活性。Atiprimod 可用于垂体腺瘤、乳腺癌、多发性骨髓瘤和急性髓系白血病 (AML) 的研究。
    Atiprimod
  • HY-14654A
    Aspirin lithium Inhibitor
    Aspirin (Acetylsalicylic Acid) lithium 是一种口服有效的不可逆的环氧合酶 COX-1COX-2 抑制剂,IC50 分别为 5 和 210 μg/mL. Aspirin lithium 诱导细胞凋亡 (apoptosis)。Aspirin lithium 可抑制 NF-κB 的活化。Aspirin lithium 还抑制血小板前列腺素合成酶 (prostaglandin synthetase),可预防冠状动脉和脑血管血栓形成。
    Aspirin lithium
  • HY-W062904
    Laquinimod sodium

    拉喹莫德钠盐

    Inhibitor
    Laquinimod (ABR-215062) sodium 是一种可口服的羧酰胺衍生物,是一种有效的免疫调节剂,可防止中枢神经系统的神经变性和炎症。Laquinimod sodium 减少星形胶质细胞 NF-κB 的活化以防止铜酮 (Cuprizone) 诱导的脱髓鞘。Laquinimod sodium 具有用于多发性硬化症 (MS;RRMS 或 CPMS) 的复发缓解 (RR) 和慢性进行性 (CP) 形式以及神经退行性疾病研究的潜力。
    Laquinimod sodium
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.